EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

Brian G. Feagan  1     Edward V. Loftus, Jr.  2     Silvio Danese  3     Severine Vermeire  4     William Sandborn  5     Tim Ritter  6     Rajiv Mehta  7     Ursula Seidler  8     Frank Seibold     Ian Beales     Hyo Jong Kim     John McNally     Chohee Yun     Sally Zhao     Xiaopeng Liu     Chantal Tasset     Robin Besuyen     Mamoru Watanabe     Stefan Schreiber     Gerhard Rogler     Toshifumi Hib    
1 Western University,London,Canada
2 Mayo Clinic College of Medicine,Rochester,United States
3 Humanitas University,Milan,Italy
4 University Hospitals Leuven,Leuven,Belgium
5 University of California San Diego,La Jolla,United States
6 GI Alliance,Southlake,United States
7 Surat Institute of Digestive Science (SIDS),Surat,India
8 Hannover Med

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing